Both in Lab Analytical Instruments
Harvard Bioscience vs Precipio
Over the past year HBIO returned +81.0% and PRPO returned +28.1%; their daily moves had a correlation of -0.08.
HBIO +81.0% PRPO +28.1%Growth of $1, one year, split-adjusted
| Metric | HBIO | PRPO |
|---|---|---|
| Price | $7.96 | $23.58 |
| Market cap | $36.2M | $42.2M |
| Today | −0.25% | −2.20% |
| 1 month | +0.4% | −18.3% |
| 6 months | +70.8% | −1.3% |
| Year to date | +19.0% | +2.6% |
| 1 year | +79.3% | +35.4% |
| Revenue growth (YoY) | +11.1% | +24.7% |
| Gross margin | 55.6% | 44.7% |
| Net margin | −12.8% | −3.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 1.5× |
| Net cash | -$30.2M | $1.9M |
| Dividend yield | — | — |
| Volatility (60d) | 39.6% | 61.9% |
| Short % of float | 1.4% | 4.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).